In addition, we compared the AR results to ER, PR, p53, body mass index (BMI), and tumor recurrence as a measure of resistance to the chemotherapy in OCs, as a sequel to our study in endometrial cancers [34]. This evidence concerns the gene PGR and neoplasm.